Intelligent Vaginal Health Management Systems

Publication ID: 24-11857580_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Vaginal Health Management Systems,” Published Technical Disclosure No. 24-11857580_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857580_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,580.

Summary of the Inventive Concept

The present inventive concept integrates Lactobacillus paracasei MG4272 strain with AI, IoT, blockchain, and nanomaterials to create a holistic, personalized, and adaptive system for vaginal health management, providing real-time monitoring, diagnosis, and treatment.

Background and Problem Solved

The original patent disclosed a composition comprising a cell-free supernatant of Lactobacillus paracasei MG4272 strain, which has antifungal and antimicrobial activities. However, the patent did not address the need for a comprehensive system that can monitor, diagnose, and treat vaginal infections in a personalized and adaptive manner. The present inventive concept solves this problem by integrating the Lactobacillus paracasei MG4272 strain with advanced technologies to provide a synergistic solution.

Detailed Description of the Inventive Concept

The inventive concept comprises a Lactobacillus paracasei MG4272 strain-based composition, an AI-powered monitoring module, an IoT-enabled vaginal ring, a blockchain-based tracking system, and a machine learning algorithm for predicting infection likelihood. The system receives input from a user's wearable device, provides personalized recommendations, and adjusts the composition's release based on the user's body temperature and pH levels. The nanomaterial-based delivery system ensures targeted release of the supernatant. The biosensor is integrated with an AI-powered diagnostic module, providing real-time results to a user's mobile device.

Novelty and Inventive Step

The integration of Lactobacillus paracasei MG4272 strain with AI, IoT, blockchain, and nanomaterials is novel and non-obvious, as it creates a holistic system that can monitor, diagnose, and treat vaginal infections in a personalized and adaptive manner. The inventive concept's synergistic combination of technologies provides a new and innovative solution that is not obvious from the original patent.

Alternative Embodiments and Variations

Alternative embodiments may include varying the type of AI algorithm used, incorporating additional sensors or tracking systems, or using different nanomaterials for delivery. Variations may include adapting the system for use in different populations or for treating different types of infections.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the women's health and wellness market, particularly in the areas of vaginal health management, infection prevention, and personalized medicine. The market for vaginal health products is expected to grow, and the present inventive concept is well-positioned to capitalize on this trend.

Original Patent Information

Patent NumberUS 11,857,580
TitleLactobacillus having antimicrobial effect on Gardnerella vaginalis and Candida albicans
Assignee(s)Mediogen Co., Ltd.